questionText: To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what steps her Department is taking to help ensure that people with less common conditions are not disproportionately impacted by additional rebates for older medicines.
answerText: Commitments in the current voluntary scheme for branded medicines pricing and access around patient access and uptake for innovative medicines have had a substantial positive impact on the speed of medicines access in England, ensuring that National Healt...
heading: Voluntary Scheme for Branded Medicines Pricing and Access